logo

NIVABUPA vs PEL: Stock Comparison

NIVA BUPA HEALTH INS CO L vs PELUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L shows faster revenue growth, while PEL shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NIVABUPA leads 2; PEL leads 6 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NIVABUPAPEL

Valuation lens

What price are you paying?

Market CapContext only
₹14,239 Cr
₹0 Cr
P/E RatioPEL has the lower reading
108.45x
43.81x ✓
P/B RatioPEL has the lower reading
3.74x
0.94x ✓
EPSPEL has the higher reading
₹1.87
₹12.19 ✓
Book ValueContext only
₹22.45
₹1,195.35
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
PEL has a lower P/E
43.81x vs 108.45x
P/B Ratio
PEL has a lower P/B
0.94x vs 3.74x
EPS
PEL has higher earnings per share
₹12.19 vs ₹1.87
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
ROE
PEL has a higher ROE
2.14% vs 0%
ROCE
PEL has a higher ROCE
10.45% vs 0%
Net Margin
PEL has a higher net margin
4.73% vs 4.34%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNIVABUPAPEL
SectorFinancial ServicesFinancial Services
IndustryGeneral InsuranceNon Banking Financial Company (NBFC)

Price

MetricNIVABUPAPEL
Live Price₹76.28₹1,124.2
Day Change0.42%0.18%
Volume5.56 L21.49 L
52-Week High₹91.4₹1,189
52-Week Low₹67.5₹1,108.5
Distance from 52W High-16.54%-5.45%

Valuation

MetricNIVABUPAPEL
Market Cap₹14,239 Cr₹0 Cr
P/E Ratio108.45x43.81x
P/B Ratio3.74x0.94x
EPS₹1.87₹12.19
Book Value₹22.45₹1,195.35
Dividend Yield0%0%

Growth

MetricNIVABUPAPEL
Revenue Growth (TTM YoY)26.8%0%
EPS Growth (TTM YoY)90.2%0%
Qtr Sales Growth—0%
Qtr Profit Growth—0%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricNIVABUPAPEL
ROE0%2.14%
ROCE0%10.45%
Net Margin4.34%4.73%
Operating Margin—59.3%
Debt to Equity0.07x1.09x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNIVABUPAPEL
Promoter Holding0%46.16%▼ 0.25 pp
FII Holding12.09%▲ 1.49 pp15.23%▼ 0.89 pp
DII Holding16.17%▼ 0.32 pp15.19%▲ 0.85 pp
Public Holding16.44%▼ 1.11 pp22.78%▼ 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NIVA BUPA HEALTH INS CO L and PEL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.